<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04779463</url>
  </required_header>
  <id_info>
    <org_study_id>Parasternal Intercostals US</org_study_id>
    <nct_id>NCT04779463</nct_id>
  </id_info>
  <brief_title>Role of Ultrasound Assessment of Parasternal Intercostal Muscle Thickness During Weaning From Mechanical Ventilation</brief_title>
  <official_title>Role of Ultrasound Assessment of Parasternal Intercostal Muscle Thickness During Weaning From Mechanical Ventilation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wesameldin Abelrahman Soltan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Menoufia University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Assessment of the the parasternal intercostal muscles thickness by the ultrasonography as a&#xD;
      weaning predictor of the mechanically ventilated patients&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      impact of parasternal muscle thickness on the weaning process of the mechanically ventilated&#xD;
      patients in ICU&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2020</start_date>
  <completion_date type="Anticipated">April 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>the thickness fraction of the parasternal intercostal muscle as a predictor of successful spontaneous breathing trials</measure>
    <time_frame>Before the start spontaneous breathing trial</time_frame>
    <description>The primary outcome is to assess the change of the parasternal intercostal muscles thickness at end of expiration and end of inspiration to verify the thickness fraction of the parasternal intercostal muscle as a predictor of successful spontaneous breathing trials.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Parasternal Intercostal Muscle Thickness</condition>
  <condition>Weaning From Mechanical Ventilation</condition>
  <arm_group>
    <arm_group_label>Mechanical Ventilated patients</arm_group_label>
    <description>All patients are invasively mechanically ventilated at least 24 hours, and are clinically stable as ready to undergo a spontaneous breathing trial.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Parasternal intercostal muscles thickness ultrasound indicies</intervention_name>
    <description>Parasternal intercostal muscles thickness ultrasound indicies includes:&#xD;
Parasternal Intercostals Thickness Fraction.&#xD;
Parasternal Intercostals Thickness at the End of Inspiration.&#xD;
Parasternal Intercostals thickness at the End of Expiration.</description>
    <arm_group_label>Mechanical Ventilated patients</arm_group_label>
    <other_name>Diaphragmatic thickness</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients are invasively mechanically ventilated at least 24 hours, and are clinically&#xD;
        stable as ready to undergo a spontaneous breathing trial (SBT).&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Any patient invasively mechanically ventilated at least 24 hours on a pressure support mode&#xD;
        who is clinically stable and ready to undergo a spontaneous breathing trial.&#xD;
&#xD;
        All patients will be:&#xD;
&#xD;
          -  Alert.&#xD;
&#xD;
          -  Afebrile.&#xD;
&#xD;
          -  Adequate cough with absence of excessive tracheobronchial secretion.&#xD;
&#xD;
          -  Fraction of inspired oxygen (FIO2) of &lt;50%.&#xD;
&#xD;
          -  PEEP ≤8 cmH2O.&#xD;
&#xD;
          -  PaO2/FiO2 &gt; 150.&#xD;
&#xD;
          -  pH ≥7.35 and ≤7.45.&#xD;
&#xD;
          -  Respiratory rate (RR) ≤35 breaths/min.&#xD;
&#xD;
          -  Hemodynamically stable in the absence of vasopressors.&#xD;
&#xD;
          -  Stable metabolic and endocrinal status.&#xD;
&#xD;
          -  Euglycemic state.&#xD;
&#xD;
          -  Adequate mentation (no sedation or stable neurologic patient).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Diaphragmatic paralysis (detected by ultrasonography).Patients&amp;Methods. 6&#xD;
&#xD;
          -  Pregnant women.&#xD;
&#xD;
          -  Age: &gt;= 18 years.&#xD;
&#xD;
          -  Surgical dressings over measurement point which would preclude ultrasound exam.&#xD;
&#xD;
          -  Underweight patients (Body mass index &lt;18.5 kg/m2).&#xD;
&#xD;
          -  Morbidly obese patient (Body mass index ≥ 40 kg/m2).&#xD;
&#xD;
          -  Primary neuro-muscular diseases.&#xD;
&#xD;
          -  Central coditions with depressed central respiratory drive (encephalitis, and&#xD;
             brainstem haemorrhage/ischaemia).&#xD;
&#xD;
          -  Repiratory conditions with reduced pulmonary compliance (interstitial lung disease,&#xD;
             pulmonary hemorrhage, and diffuse pulmonary infiltrates) or reduced chest wall&#xD;
             compliance (kyphoscoliosis).&#xD;
&#xD;
          -  Cardiac conditions with high risk of weaning induced pulmonary edema (congestive heart&#xD;
             failure, cyanotic heart diease, pulmonary hypertension, and ischemic heart diease).&#xD;
&#xD;
          -  Addict patients.&#xD;
&#xD;
          -  Patients with psychiatric disease.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wesameldin A Soltan, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>faculty of medicine, Menoufia University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Wesameldin A Soltan, M.D.</last_name>
    <phone>0020101012215</phone>
    <email>wesamsultan1@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Faculty of Medicine - Menoufia University</name>
      <address>
        <city>Shibīn Al Kawm</city>
        <state>Menoufia</state>
        <zip>32511</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Muhammad A AlGhorayeb, MD</last_name>
      <phone>+201000203165</phone>
      <email>drmsebaey@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 27, 2021</study_first_submitted>
  <study_first_submitted_qc>February 27, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 3, 2021</study_first_posted>
  <last_update_submitted>February 27, 2021</last_update_submitted>
  <last_update_submitted_qc>February 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Menoufia University</investigator_affiliation>
    <investigator_full_name>Wesameldin Abelrahman Soltan</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>mechanical ventilation, parasternal muscle thickness</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

